Battle of the beauty devices: L’Oreal takes Clarisonic 'imitator' to court

By Michelle Yeomans contact

- Last updated on GMT

Battle of the beauty devices: L’Oreal takes Clarisonic 'imitator' to court
L’Oréal has launched legal proceedings against Australia's 'BrandPoint', stating it has been 'misleading and deceptive' with claims for its 'PuraSonic' product by comparing it to the global players' Clarisonic skin care technology.

L’Oreal acquired Clarisonic from Pacific Bioscience Laboratories in 2011, which BrandPoint had been a distributor of from 2010 until 2012 until the agreement expired.  

Following this, the Queensland business launched the PuraSonic facial cleansing brush along with promotional material that claimed the technology had similar “efficacy research​” as Clarisonic but was "retailed at a lower price."

In the Federal Court, legal reps for L’Oréal claimed​ that BrandPoint; “made misleading, deceptive or false claims as to the performance of PuraSonic in a promotional email sent to retailers and on the product’s website."

The email allegedly featured research results similar to those referred to in the marketing material conducted before 2008 for the Clarisonic product.

The international beauty player also claimed that there was no 'appropriate trials, testing or analysis' of PuraSonic at the time the email was sent out.

Judge calls for evidence to back PuraSonic's claims...

In response, BrandPoint stated that the email was a 'draft sent in error' to 26 retailers and argued that L’Oréal had had the opportunity to purchase and conduct testing on PuraSonic in order to impugn the representations, but had chosen not to do so.

Counsel for the defendant, Ms Cochrane then submitted that there was no evidence that the representations regarding PuraSonic were misleading or false and that there was no evidence that the emails conflicted with the company's website representations.

On hearing both sides of the argument, Justice Jonathan Beach described BrandPoint’s evidence in relation to the efficacy research to be “thin, if not evasive” ​and that while there was evidence to support the later website representations, there was “only a vague implication” that testing may have been conducted at the time the email was sent.

More generally, inaccurate or misleading representations about the performance of BrandPoint’s product would have been likely to have had a potential impact on the market for sonic facial cleansing brushes generally and therefore L’Oréal Australia’s commercial interests," ​Beach ruled.

The judge then ordered the discovery of relevant documents by BrandPoint by September 30th. will follow this case as it progresses.

Related topics: Business & Financial, Oceania, Skin Care

Related news

Show more

Related products

show more

Change the Game with Water-Soluble Salicylic Acid!

Change the Game with Water-Soluble Salicylic Acid!

Tagra Biotechnologies | 28-Oct-2019 | Product Presentation

Watch Tagra’s Water Soluble Salicylic Acid WS SA50TM how-to video to see how to make alcohol-free formulas, sensitive skin formulas, and many more! WS...

BODY'licious, when body becomes the new face!

BODY'licious, when body becomes the new face!

SEPPIC | 21-Oct-2019 | Technical / White Paper

Seppic presents its new body care formulas collection: BODY’licious. Consumers are getting more demanding in terms of body product sensoriality and functionality:...

Microbiome-friendly long lasting deo

Microbiome-friendly long lasting deo

Symrise | 11-Oct-2019 | Product Brochure

SymDeo® B125 is a patented and simple aliphatic alcohol. It supports especially long lasting protection against body odor. While deodorants alone are typically...

Related suppliers

Follow us

Featured Events

View more


View more


Indie Pioneers Podcast

Indie Pioneers Podcast